Total Payments
$182,042
2024 Payments
$29,241
Companies
11
Transactions
201
Medicare Patients
30,140
Medicare Billing
$8.5M
Payment Breakdown by Category
Other$147,525 (81.0%)
Consulting$20,440 (11.2%)
Travel$8,917 (4.9%)
Food & Beverage$4,890 (2.7%)
Education$269.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $77,600 | 17 | 42.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,925 | 18 | 38.4% |
| Consulting Fee | $20,440 | 10 | 11.2% |
| Travel and Lodging | $8,917 | 49 | 4.9% |
| Food and Beverage | $4,890 | 103 | 2.7% |
| Education | $269.71 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $179,839 | 152 | $0 (2024) |
| UCB, Inc. | $1,422 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $330.50 | 14 | $0 (2024) |
| ABBVIE INC. | $197.33 | 12 | $0 (2024) |
| Lilly USA, LLC | $103.06 | 4 | $0 (2024) |
| PFIZER INC. | $48.36 | 3 | $0 (2024) |
| Celgene Corporation | $27.05 | 1 | $0 (2018) |
| Mylan Pharmaceuticals Inc. | $21.68 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $20.90 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $16.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,241 | 49 | SUN PHARMACEUTICAL INDUSTRIES INC. ($28,838) |
| 2023 | $42,297 | 60 | Sun Pharmaceutical Industries Inc. ($41,864) |
| 2022 | $27,480 | 23 | Sun Pharmaceutical Industries Inc. ($26,226) |
| 2021 | $70,217 | 51 | SUN PHARMACEUTICAL INDUSTRIES INC. ($70,166) |
| 2020 | $12,655 | 13 | Sun Pharmaceutical Industries Inc. ($12,655) |
| 2019 | $88.49 | 2 | Sun Pharmaceutical Industries Inc. ($88.49) |
| 2018 | $27.05 | 1 | Celgene Corporation ($27.05) |
| 2017 | $36.01 | 2 | Mylan Pharmaceuticals Inc. ($21.68) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $133.01 | General |
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Immunology | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $450.24 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $248.57 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $41.18 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $31.11 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Immunology | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,415.00 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $116.03 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $313.56 | General |
| Category: Dermatology | ||||||
| 09/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $186.26 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,415.00 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | In-kind items and services | $342.99 | General |
| Category: Dermatology | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,971.00 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $68.20 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 9,054 | 29,048 | $6.7M | $2.8M |
| 2022 | 50 | 6,889 | 22,988 | $5.0M | $2.1M |
| 2021 | 54 | 7,290 | 22,026 | $4.3M | $1.9M |
| 2020 | 54 | 6,907 | 19,058 | $3.7M | $1.6M |
Total Patients
30,140
Total Services
93,120
Medicare Billing
$8.5M
Procedure Codes
220
All Medicare Procedures & Services
220 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 38 | 12,500 | $2.8M | $1.4M | 49.9% |
| Q4190 | Artacent ac, per square centimeter | Office | 2023 | 46 | 1,042 | $974,313 | $414,504 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,733 | 2,948 | $558,271 | $185,588 | 33.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,702 | 2,860 | $412,870 | $159,980 | 38.7% |
| Q4169 | Artacent wound, per square centimeter | Office | 2023 | 18 | 460 | $288,497 | $146,107 | 50.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,054 | 1,503 | $207,996 | $52,761 | 25.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 190 | 284 | $99,059 | $36,978 | 37.3% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 59 | 244 | $75,676 | $26,669 | 35.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 332 | 393 | $92,551 | $25,173 | 27.2% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 242 | 280 | $82,164 | $25,160 | 30.6% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 265 | 312 | $80,670 | $23,415 | 29.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 47 | 51 | $51,227 | $19,707 | 38.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 39 | 64 | $40,102 | $19,557 | 48.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 115 | 147 | $55,352 | $17,829 | 32.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 115 | 146 | $54,575 | $16,833 | 30.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 641 | 2,895 | $38,700 | $14,776 | 38.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 42 | $38,123 | $14,047 | 36.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 80 | 88 | $45,479 | $13,648 | 30.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 200 | 213 | $45,482 | $13,267 | 29.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 130 | 153 | $44,722 | $13,141 | 29.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 145 | 162 | $34,590 | $12,887 | 37.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 67 | 78 | $46,235 | $12,478 | 27.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 113 | 132 | $40,859 | $12,197 | 29.9% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 57 | 74 | $32,027 | $10,994 | 34.3% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 124 | 147 | $27,707 | $10,061 | 36.3% |
About Dr. Laertes Manuelidis, M.D
Dr. Laertes Manuelidis, M.D is a Dermatopathology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245220698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laertes Manuelidis, M.D has received a total of $182,042 in payments from pharmaceutical and medical device companies, with $29,241 received in 2024. These payments were reported across 201 transactions from 11 companies. The most common payment nature is "Honoraria" ($77,600).
As a Medicare-enrolled provider, Manuelidis has provided services to 30,140 Medicare beneficiaries, totaling 93,120 services with total Medicare billing of $8.5M. Data is available for 4 years (2020–2023), covering 220 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Procedural Dermatology
- Location Fort Myers, FL
- Active Since 10/26/2005
- Last Updated 09/11/2025
- Taxonomy Code 207ZD0900X
- Entity Type Individual
- NPI Number 1245220698
Products in Payments
- ILUMYA (Biological) $109,128
- Ilumya (Biological) $70,166
- TREMFYA (Drug) $278.78
- Cimzia (Drug) $216.71
- SKYRIZI (Biological) $130.88
- TALTZ (Drug) $103.06
- RINVOQ (Biological) $66.45
- Absorica LD (Drug) $47.20
- REMICADE (Biological) $37.39
- EUCRISA (Drug) $31.40
- Otezla (Drug) $27.05
- Bimzelx (Biological) $25.74
- Clindamycin Phosphate and Benzoyl Peroxide (Drug) $21.68
- DUPIXENT (Biological) $20.90
- Winlevi (Drug) $20.12
- BLU-U (Medical Supply) $19.37
- CIBINQO (Drug) $16.96
- OPZELURA (Drug) $15.00
- GUSELKUMAB (Biological) $14.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.